3-n-butylphthalide has been researched along with Parkinson Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Cai, H; Ge, J; He, X; Xie, T; Yao, C; Ye, XY; Zhong, Z; Zhu, J | 1 |
| Chang, Z; Huang, Z; Jin, D; Li, H; Que, R; Tan, EK; Wang, HT; Wang, Q; Xie, Z; Xu, J; Yang, W; Zhang, W; Zheng, J | 1 |
| Buzoianu, AD; Feng, L; Lafuente, JV; Muresanu, DF; Nozari, A; Sharma, A; Sharma, HS; Tian, ZR; Wang, Z; Wiklund, L | 1 |
| Buzoianu, AD; Feng, L; Huang, H; Lafuente, JV; Li, C; Lin, C; Manzhulo, I; Muresanu, DF; Nozari, A; Sharma, A; Sharma, HS; Tian, ZR; Wang, Z; Wiklund, L; Zhang, Z | 1 |
| Buzoianu, AD; Chen, L; Feng, L; Huang, H; Lafuente, JV; Manzhulo, I; Muresanu, DF; Nozari, A; Sharma, A; Sharma, HS; Tian, ZR; Wang, ZG; Wiklund, L | 1 |
| Buzoianu, AD; Castellani, RJ; Feng, L; Lafuente, JV; Muresanu, DF; Niu, F; Nozari, A; Patnaik, R; Sahib, S; Sharma, A; Sharma, HS; Tian, ZR; Wang, Z; Wiklund, L | 1 |
| Chen, YH; Ge, BB; Jiang, MJ; Li, L; Liu, H; Qu, HD; Qu, XL; Xu, JJ; Xu, L | 1 |
| Chen, Q; Li, M; Lin, W; Zhang, X; Zhong, R | 1 |
3 review(s) available for 3-n-butylphthalide and Parkinson Disease
| Article | Year |
|---|---|
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.
Topics: Biological Products; Blood-Brain Barrier; Dopaminergic Neurons; Humans; Neurodegenerative Diseases; Parkinson Disease | 2022 |
Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson's Disease Following Concussi
Topics: alpha-Synuclein; Antibodies, Monoclonal; Brain Injuries, Traumatic; DNA-Binding Proteins; Humans; Mesenchymal Stem Cells; Nanowires; Neuroprotection; Neuroprotective Agents; Parkinson Disease | 2023 |
L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia: A systematic review and meta-analysis of randomized controlled trials.
Topics: Antiparkinson Agents; Benzofurans; Capsules; Dementia; Humans; Nootropic Agents; Parkinson Disease; Randomized Controlled Trials as Topic | 2019 |
5 other study(ies) available for 3-n-butylphthalide and Parkinson Disease
| Article | Year |
|---|---|
Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
Topics: alpha-Synuclein; Animals; Apoptosis; Benzofurans; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Humans; Inflammasomes; Mice; Mitochondria; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinson Disease; Protein Aggregation, Pathological | 2021 |
Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress.
Topics: alpha-Synuclein; Antibodies; Brain; Humans; Neuroprotection; Parkinson Disease; Psychological Distress | 2023 |
Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain Concussion; Humans; Neprilysin; Neuroprotection; Neuroprotective Agents; Parkinson Disease | 2023 |
Co-administration of TiO
Topics: Benzofurans; Brain Injuries, Traumatic; Humans; Mesenchymal Stem Cells; Neuroprotection; Parkinson Disease; Titanium | 2020 |
Protective effects of DL‑3‑n‑butylphthalide in the lipopolysaccharide‑induced mouse model of Parkinson's disease.
Topics: Animals; Apoptosis; Benzofurans; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Lipopolysaccharides; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rotarod Performance Test; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |